Evidence map›Paper›PMID 22025500›Full record

ReviewThe Journal of experimental medicine2011

Unraveling the basic biology and clinical significance of the chlamydial plasmid.

Daniel D Rockey

Open access · bronzeAbstract readReview
In one paragraph

Review in The Journal of experimental medicine, 2011. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 26 papers.

0numbers the graph read from it
0cells of the map it votes in
26citing papers in PubMed
3.1field-weighted citation impact, top 10% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

26 citing papers in PubMed, 49 citations in OpenAlex.

  1. Article
  2. Microorganisms · 2023
    Review
  3. Article
  4. Article
  5. Genome organization and genomics inFrontiers in cellular and infection microbiology · 2023
    Review
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Microorganisms · 2019
    Review
  13. Article
  14. TheWellcome open research · 2018
    Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

1 author at 1 institution in 1 country.

Daniel D RockeyDepartment of Biomedical Sciences, Oregon State University College of Veterinary Medicine, Corvallis, OR 97331, USA. rockeyd@orst.edu
Oregon State University · US

Funding

Recombination and Genetics in Chlamydia spp.RC1AI086469 · NIAID · OREGON STATE UNIVERSITY · PI ROCKEY, DANIEL D · 2009 to 2010
$993k
Genetic transformation system for Chlamydia suisR21AI069214 · NIAID · OREGON STATE UNIVERSITY · PI ROCKEY, DANIEL D · 2006 to 2007
$343k
NIAID NIH HHS AI069214NIAID NIH HHS AI086469NIAID NIH HHS R21 AI069214NIAID NIH HHS RC1 AI086469
6 · The paper itself

Abstract

Chlamydial plasmids are small, highly conserved, nonconjugative, and nonintegrative DNA molecules that are nearly ubiquitous in many chlamydial species, including Chlamydia trachomatis. There has been significant recent progress in understanding chlamydial plasmid participation in host-microbe interactions, disease, and immune responses. Work in mouse model systems and, very recently, in nonhuman primates demonstrates that plasmid-deficient chlamydial strains function as live attenuated vaccines against genital and ocular infections. Collectively, these studies open new avenues of research into developing vaccines against trachoma and sexually transmitted chlamydial infections.

Indexed as

DNA, BacterialAnimalsChlamydia InfectionsChlamydia trachomatisHumansPlasmidsVaccines, AttenuatedDNA, BacterialVaccines, Attenuated

Identifiers

PMID22025500
PMCPMC3201210
OpenAlexW2035924787

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-SA
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.